Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF and Nanohydroxyapatite in Intrabony Defects
NCT02810548Phase 1Completed
- Sponsor
- King Abdulaziz University
- Start
- Feb 2015
- Primary completion
- Nov 2016
- Modality
- Hydrogel Systems, Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised trial of platelet rich fibrin and nanohydroxyapatite in chronic periodontitis (4 arms), sponsored by King Abdulaziz University. Primary endpoint: Gingival crevicular fluid at 3 weeks. Started Feb 2015; status: completed.
02
Drugs
platelet rich fibrinnanohydroxyapatite
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02810548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810548.